We are live on ! Find out more
PAWC

P.A.W. Capital Portfolio holdings

AUM $131M
1-Year Est. Return 35.16%
This Fund
S&P 500
This Quarter Est. Return
+11.81%
1 Year Est. Return
+35.16%
3 Year Est. Return
+54.62%
5 Year Est. Return
+52.46%
10 Year Est. Return
+1,343.69%
AUM
$99M
AUM Growth
+$15.7M
Cap. Flow
+$670K
Cap. Flow %
0.68%
Top 10 Hldgs %
41.42%
Holding
71
New
10
Increased
19
Reduced
22
Closed
7

Top Buys

Rank Stock Value
1
SMLR
Semler Scientific
SMLR
+$1.39M
2
EFII
Electronics for Imaging
EFII
+$1.27M
3
AKBA icon
Akebia Therapeutics
AKBA
+$1M
4
APPS icon
Digital Turbine
APPS
+$857K
5
CLLS
Cellectis
CLLS
+$789K

Top Sells

Rank Stock Value
1
WEB
Web.com Group, Inc.
WEB
+$2.17M
2
WIFI
Boingo Wireless, Inc.
WIFI
+$991K
3
RCM
R1 RCM Inc. Common Stock
RCM
+$809K
4
CHGG icon
Chegg
CHGG
+$754K
5
VRNS icon
Varonis Systems
VRNS
+$719K

Sector Composition

Rank Sector Weight
1 Technology 30.36%
2 Healthcare 15.29%
3 Communication Services 14.01%
4 Consumer Staples 10.33%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLLS
26
Cellectis
CLLS
$139M
$1.13M 1.14%
40,000
+26,500
+196% +$789K
EOCN
27
Eocene Ltd. Ordinary Shares
EOCN
$3.64M
$1.13M 1.14%
66
-3
-4% -$34.7K
CCXI
28
DELISTED
ChemoCentryx, Inc.
CCXI
$1.12M 1.13%
85,000
+10,000
+13% +$120K
EIGR
29
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.1M 1.11%
3,000
-1,500
-33% -$534K
TREE icon
30
LendingTree
TREE
$373M
$1.07M 1.08%
5,000
– –
AKBA icon
31
Akebia Therapeutics
AKBA
$254M
$998K 1.01%
+100,000
New +$1M
ONCE
32
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$993K 1%
+12,000
New +$926K
RDS.A
33
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$831K 0.84%
12,000
-500
-4% -$34.6K
LKFT
34
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
$830K 0.84%
9,000
– –
VZ icon
35
Verizon
VZ
$207B
$755K 0.76%
15,000
-1,500
-9% -$72.6K
KHC icon
36
The Kraft Heinz Company
KHC
$29.3B
$691K 0.7%
+11,000
New +$653K
MO icon
37
Altria Group
MO
$117B
$681K 0.69%
12,000
+2,000
+20% +$115K
MRK icon
38
Merck
MRK
$358B
$668K 0.67%
11,528
-1,048
-8% -$59.1K
JNJ icon
39
Johnson & Johnson
JNJ
$644B
$667K 0.67%
5,500
+500
+10% +$62.4K
DD icon
40
DuPont de Nemours
DD
$17.2B
$659K 0.67%
3,949
– –
KO icon
41
Coca-Cola
KO
$378B
$658K 0.66%
15,000
– –
PEP icon
42
PepsiCo
PEP
$183B
$653K 0.66%
6,000
– –
PFE icon
43
Pfizer
PFE
$157B
$653K 0.66%
18,972
-2,108
-10% -$72K
PM icon
44
Philip Morris
PM
$299B
$646K 0.65%
8,000
+1,000
+14% +$84.9K
GSK icon
45
GSK
GSK
$101B
$645K 0.65%
12,800
– –
BP icon
46
BP
BP
$117B
$639K 0.65%
14,874
-2,346
-14% -$98.6K
CVX icon
47
Chevron
CVX
$415B
$632K 0.64%
5,000
-500
-9% -$62.1K
PG icon
48
Procter & Gamble
PG
$341B
$624K 0.63%
8,000
+500
+7% +$37.6K
OHI icon
49
Omega Healthcare
OHI
$14.2B
$620K 0.63%
20,000
-5,000
-20% -$143K
XOM icon
50
ExxonMobil
XOM
$672B
$620K 0.63%
+7,500
New +$598K
1
2
3

Similar funds

ACM
Ativo Capital Management Chicago, Illinois $131M AUM 19.64% 1-Year Est. Return
NFS
NewCorp Financial Services Alpharetta, Georgia $131M AUM
GFA
Godfrey Financial Associates Glenmont, New York $131M AUM
WHC
Wulff, Hansen & Co San Rafael, California $130M AUM 31.91% 1-Year Est. Return
HGP
Haven Global Partners Atlanta, Georgia $130M AUM 38.26% 1-Year Est. Return
SCC
Seal Cove Capital Palo Alto, California $130M AUM
B
Bayban Bayport, Minnesota $130M AUM
PCOTEOTHU
Provident Company of the Employees of the Hebrew University Jerusalem, Israel $131M AUM 66.95% 1-Year Est. Return

P.A.W. Capital's Q2 2018 Portfolio in Review

As of Q2 2018, P.A.W. Capital held 71 positions worth $99M, up 19% from $83.2M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

P.A.W. Capital's Q2 2018 filing shows 10 new, 19 increased, 22 reduced and 7 closed positions. Its largest new stake was Semler Scientific: 90,000 shares worth $1.39M. The largest sale was Web.com Group, Inc., an estimated $2.17M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 35% a quarter earlier, followed by Healthcare and Communication Services.

  • P.A.W. Capital's largest Q2 2018 buy was Semler Scientific: 90,000 shares worth $1.39M.
  • P.A.W. Capital added most to Electronics for Imaging in Q2 2018, an estimated $1.27M increase.
  • P.A.W. Capital's biggest Q2 2018 reduction was R1 RCM Inc. Common Stock, cutting an estimated $809K.
  • P.A.W. Capital fully exited Web.com Group, Inc. in Q2 2018, selling an estimated $2.17M.
  • P.A.W. Capital's ten largest holdings make up 41% of its $99M portfolio in Q2 2018.
  • P.A.W. Capital opened 10 new positions and closed 7 in Q2 2018.
  • P.A.W. Capital's portfolio value rose 19% quarter-over-quarter to $99M.

Based on P.A.W. Capital's 13F filing for Q2 2018, filed 25 Jul 2018.